See What HealthDay Can Do For You
Contact Us

Tension-Free Vaginal Tape Effective in Long Term

Objective and subjective stress incontinence cure rate of 89.8 and 82.4 percent, respectively

THURSDAY, Oct. 13 (HealthDay News) -- For women with stress urinary incontinence, treatment with tension-free vaginal tape (TVT) is associated with a high long-term cure rate with no adverse effects, according to a study published in the October issue of Urology.

Andreas Reich, from the University of Ulm in Germany, and colleagues investigated the long-term effectiveness and late complications of TVT in treatment of female stress urinary incontinence. A total of 108 patients with stress urinary incontinence (68.8 percent of the initial cohort and 79.6 percent of the cohort who were alive and cooperative) were assessed by standardized questionnaire, medical history, voiding diary, gynecologic examination with cough test, and introital ultrasound. Participants were followed up for an average of 102 months.

The investigators found that the objective and subjective cure rate was 89.8 and 82.4 percent, respectively. A total of 13 percent of women felt their incontinence had improved, 2.8 percent felt no change in their incontinence situation, and 1.8 percent had impaired stress urinary incontinence. Surgery did not result in any late-onset adverse effects. In 90 percent of patients with discontent, the main reason for dissatisfaction with surgery was urge incontinence.

"The TVT procedure leads to an ongoing high surgical success rate, the main reason for long-term dissatisfaction is urge incontinence, originating from a preexisting or a de novo disturbance," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.